Literature DB >> 25897105

Breast cancer metastasis - insight into selected molecular mechanisms of the phenomenon.

Jarosław Kozłowski1, Aleksandra Kozłowska2, Janusz Kocki3.   

Abstract

Metastasis is a complex, multistep biological process, involving a multitude of genes and biomolecules. Despite the successful therapeutic management of breast cancer, including surgery, chemotherapy and radiation therapy, that can control primary tumor growth, metastatic disease remains the greatest clinical challenge in oncology, as these methods are still not very effective in preventing relapses or in the management of breast cancer metastases. The knowledge of its mechanisms is still fragmentary and needs to be broadened in order to improve our therapeutic approach and influence on the long-term control of breast cancer progression. Despite the constant progress in understanding of breast cancer progression, it remains a major health problem around the world. Novel therapeutic modalities are being tested and developed, but the incidence and mortality rates are still frightening. In this paper, we review selected aspects of breast cancer metastasis, including the metastatic cascade and models of dissemination, tumor angiogenesis, disaggregation and migration of cells from the primary tumor, breaking the vascular wall, adaptation to a new environment, organotropism and dormant cells. The interactions between cancer cells and normal host cells contributing significantly to the metastatic cascade are highlighted, and a wide range of signaling and stimulating biomolecules and genes involved in the process are introduced.

Entities:  

Mesh:

Year:  2015        PMID: 25897105     DOI: 10.5604/17322693.1148710

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  40 in total

1.  Does Age Matter? Estimating Risks of Locoregional Recurrence After Breast-conservative Surgery.

Authors:  Gianluca Vanni; Marco Materazzo; Marco Pellicciaro; Ljuba Morando; Ilaria Portarena; Lucia Anemona; Maria Rolando D'Angelillo; Rosaria Barbarino; Agostino Chiaravalloti; Rosaria Meucci; Tommaso Perretta; Camilla Deiana; Paolo Orsaria; Jonathan Caspi; Chiara Adriana Pistolese; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Three dimensional engineered models to study hypoxia biology in breast cancer.

Authors:  Vaishali Aggarwal; Oshin Miranda; Paul A Johnston; Shilpa Sant
Journal:  Cancer Lett       Date:  2020-06-20       Impact factor: 8.679

3.  EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.

Authors:  Xinlu Wang; Minying Zheng; Fei Fei; Chunyuan Li; Jiaxing Du; Kai Liu; Yuwei Li; Shiwu Zhang
Journal:  Med Oncol       Date:  2019-08-12       Impact factor: 3.064

4.  Natriuretic peptide receptor a promotes breast cancer development by upregulating MMP9.

Authors:  Jingkun Qu; Xixi Zhao; Xu Liu; Yuchen Sun; Jizhao Wang; Lin Liu; Jiansheng Wang; Jia Zhang
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

5.  Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter.

Authors:  Yufei Liu; Jun Zhou; Yuchang Hu; Junjie Wang; Chengfu Yuan
Journal:  Mol Cell Biochem       Date:  2016-11-10       Impact factor: 3.396

6.  Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion.

Authors:  Abrar I Aljohani; Michael S Toss; Khloud A El-Sharawy; Sameer Mirza; Graham R Ball; Andrew R Green; Emad A Rakha
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

7.  Solute carrier family 12 member 8 impacts the biological behaviors of breast carcinoma cells by activating TLR/NLR signaling pathway.

Authors:  LinWei Li; Jing Xia; RuTing Cui; Bin Kong
Journal:  Cytotechnology       Date:  2020-11-11       Impact factor: 2.058

Review 8.  Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Authors:  Yunchun Zhao; Xiaoling Zheng; Yongquan Zheng; Yue Chen; Weidong Fei; Fengmei Wang; Caihong Zheng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

9.  Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis.

Authors:  Huiping Li; Cuizhi Geng; Hongmei Zhao; Hanfang Jiang; Guohong Song; Jiayang Zhang; Yaxin Liu; Xinyu Gui; Jing Wang; Kun Li; Zhongsheng Tong; Fangyuan Zhao; Junlan Yang; Guoliang Chen; Qianyu Liu; Xu Liang
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

10.  Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis.

Authors:  Nehal Gupta; Sanjay K Srivastava
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.